SCN1A and epilepsy: This observation is particularly interesting in that others have noted a strong correlation between maximum prescribed dose of phenytoin or carbemazepine in epilepsy and genetic variants in CYP2C9 or SCN1A , suggesting clinical adjustment of dose in response to genotype [44].